Alembic Pharmaceuticals is currently trading at Rs. 505.80, up by 3.75 points or 0.75% from its previous closing of Rs. 502.05 on the BSE.
The scrip opened at Rs. 500.30 and has touched a high and low of Rs. 506.35 and Rs. 499.00 respectively. So far 742 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 664.00 on 27-Sep-2018 and a 52 week low of Rs. 478.05 on 14-Jun-2018.
Last one week high and low of the scrip stood at Rs. 515.65 and Rs. 492.00 respectively. The current market cap of the company is Rs. 9406.94 crore.
The promoters holding in the company stood at 72.97%, while Institutions and Non-Institutions held 14.98% and 12.05% respectively.
Alembic Pharmaceuticals’ board has approved the issue of Unsecured Listed Rated Redeemable Non-Convertible Debentures (NCDs) of upto Rs 300 crore on private placement basis in one or more tranches. The Board of directors of the company at its meeting held on June 12, 2019 has approved for the same.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.
